NATIONALLY RANKED ROSEN LAW FIRM Encourages Talis Biomedical Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – TLIS
January 14, 2022 15:35 ET
|
The Rosen Law Firm PA
NEW YORK, Jan. 14, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of...
OCGN BREAKING NOTICE: ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Ocugen, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – OCGN
August 06, 2021 10:37 ET
|
The Rosen Law Firm PA
NEW YORK, Aug. 06, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ocugen, Inc. (NASDAQ: OCGN) between February 2, 2021 and...
GTX Corp Adds Rapid Diagnostic Test Kits for the SARS-COV-2 (COVID-19) Antigen
February 18, 2021 08:35 ET
|
GTX Corp
LOS ANGELES, CALIFORNIA, Feb. 18, 2021 (GLOBE NEWSWIRE) -- GTX Corp (OTC: GTXO) (“GTX” or the “Company”), a pioneer in the field of wearable GPS human and asset tracking systems and a supplier of...
Global WholeHealth Partners Corp. (GWHP) Announces It Had Submitted an Emergency Use Authorization (EUA) Application # PEUA201789 Date 09/14/2020: for the Global Antigen CoViD19 SARS2 Rapid Test as Mentioned in the 8K Filing on 09/15/20
September 21, 2020 07:00 ET
|
Global WholeHealth Partners Corp.
SAN CLEMENTE, CA, Sept. 21, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Global WholeHealth Partners Corp. (GWHP) announces it had submitted an Emergency Use Authorization (EUA) Application...
Aditxt Submits Emergency Use Authorization (EUA) Application for AditxtScore™ for COVID-19
August 24, 2020 08:30 ET
|
Aditx Therapeutics, Inc.
If Granted, EUA would Enable the Commercial Launch of AditxtScore for COVID-19 LOMA LINDA, CA, Aug. 24, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Aditx Therapeutics, Inc. (Aditxt) (the...
REMSleep Flagship Product Deltawave CPAP Interface
May 04, 2020 06:00 ET
|
REMSleep Holdings, Inc.
REMSleep Proceeds to File for Emergency Use Authorization from the FDA for its Deltawave CPAP Interface TAMPA, FL, May 04, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – REMSleep Holdings, Inc. (OTC...
Developer of PharmaCyte Biotech’s COVID-19 Test Explains Why His Test Is So Highly Sensitive, Path to FDA EUA, and Commercialization
April 20, 2020 09:00 ET
|
PharmaCyte Biotech
NEW YORK, NY, April 20, 2020 (GLOBE NEWSWIRE) -- PharmaCyte Biotech (OTCQB: PMCB) recently entered into a licensing agreement with Hai Kang Life Corporation (Hai Kang), where Hai Kang granted to...
PharmaCyte Biotech to Offer COVID-19 Testing While Creating Revenue Stream for Pancreatic Cancer Program
April 13, 2020 09:00 ET
|
PharmaCyte Biotech
NEW YORK, NY, April 13, 2020 (GLOBE NEWSWIRE) -- PharmaCyte Biotech (OTCQB: PMCB) is a California-based biotechnology company focused on developing cellular therapies for cancer and diabetes using...